Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Insmed's share price for the quarter that ended in Mar. 2026 was MXN3760. Insmed's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 217 Mil. Therefore, Insmed's market cap for the quarter that ended in Mar. 2026 was MXN814,123 Mil.
Insmed's quarterly market cap
increased
from Sep. 2025 (MXN511,883 Mil) to Dec. 2025 (MXN805,603 Mil) and
increased
from Dec. 2025 (MXN805,603 Mil) to Mar. 2026 (MXN814,123 Mil).
Insmed's annual market cap
increased
from Dec. 2023 (MXN72,289 Mil) to Dec. 2024 (MXN87,630 Mil) and
increased
from Dec. 2024 (MXN87,630 Mil) to Dec. 2025 (MXN805,603 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Insmed's Enterprise Value for Today is MXN412,511 Mil.
Insmed (MEX:INSM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Insmed Market Cap Related Terms
Insmed Market Cap Historical Data
* Premium members only.
The historical data trend for Insmed's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:INSM vs INCY, BNTX, ROIV: Market Cap Comparison
For the Biotechnology subindustry, Insmed's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insmed Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Insmed's Market Cap distribution charts can be found below:
* The bar in red indicates where Insmed's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Insmed's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insmed (MEX:INSM) has a Market Cap of MXN423,780 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Insmed and its competitors. According to the industry distribution chart, Insmed ranks #15 out of 1422 companies in the Biotechnology industry, placing it in the top 1.1%.
Is Insmed's Market Cap too high?
Insmed's current Market Cap is MXN423,780 Mil. Based on the distribution chart, Insmed ranks #15 out of 1422 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Insmed has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Insmed's Market Cap compare to INCY and BNTX?
According to the Biotechnology industry distribution chart, Insmed ranks #15 out of 1422 companies for Market Cap. This places Insmed in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 120.73, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Insmed and its competitors. For the Biotechnology industry, the median Market Cap is 120.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Insmed's current Market Cap is MXN423,780 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insmed stock overvalued right now?
Insmed (MEX:INSM) has a current Market Cap of MXN423,780 Mil. The stock's GF Value™ is MXN5,773.42, compared to a current price of MXN3,760.00 — trading 34.9% below its estimated fair value. The current Market Cap is MXN423,780 Mil. Insmed's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Insmed (MEX:INSM), the current Market Cap is MXN423,780 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Insmed (MEX:INSM) Overvalued in 2026?
Based on GuruFocus' analysis, Insmed stock appears to be undervalued.
The current stock price of MXN3,760.00 is trading 34.9% below its estimated GF Value™ of MXN5,773.42.
Key valuation signals for MEX:INSM:
Market Cap: MXN423,780 Mil
GF Value™: MXN5,773.42 vs. price of MXN3,760.00 (34.9% below fair value)
No single metric tells the full story. See the MEX:INSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
68GF Score
Get the complete analysis for MEX:INSM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:INSM has been successfully added to your 
